NCT06323226 The Impact of Sepsis on Long-term Outcomes in Critical Ill Children With Sepsis
| NCT ID | NCT06323226 |
| Status | Recruiting |
| Phase | — |
| Sponsor | West China Hospital |
| Condition | Sepsis |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2019-01-01 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2019-01-01 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is conducted in critically ill children with sepsis with a five years follow-up. We aim to investigate the impact of sepsis on long-term outcomes including growth, neurodevelopment, survival rate, quality of life.
Eligibility Criteria
Inclusion Criteria: We included critically ill children with sepsis who successfully discharged from pediatric Intensive care units, age \< 16 years. We also included age, sex, illness severity matched critically ill children as control group. Exclusion Criteria: We excluded children with underlying diseases, cancer, hematologic malignancy.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06323226 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, up to 16 Years, studying Sepsis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06323226 currently recruiting?
Yes, NCT06323226 is actively recruiting participants. Contact the research team at jijiyuanyuan@163.com for enrollment information.
Where is the NCT06323226 trial being conducted?
This trial is being conducted at Chengdu, China.
Who is sponsoring the NCT06323226 clinical trial?
NCT06323226 is sponsored by West China Hospital. The trial plans to enroll 300 participants.